Safety and Immunogenicity of a Vaccine Against Coxsackieviruses B (PRV-101)-Follow-up of the First-in-Human Phase 1 Trial. [PDF]
Laiho JE +10 more
europepmc +1 more source
Centers for Disease Control and Prevention. 2019. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2019.Publication date from document properties.HFLU_Surveillance_Report_2019 ...
core
Onychomadesis: A Rare Manifestation of Coxsackievirus A6 Infection in an Adult Patient. [PDF]
Panayiotou C +4 more
europepmc +1 more source
Hand, Foot, and Mouth Disease Surveillance in Anhui, After Introduction of the Enterovirus 71 Vaccine and During the COVID-19 Pandemic: Ecological Interrupted Time Series Study. [PDF]
Li K +8 more
europepmc +1 more source
Suppression of Calpain Attenuates Coxsackievirus B3-Induced Myocarditis by Regulating RIPK1/RIPK3/MLKL Pathway. [PDF]
Liu Y +7 more
europepmc +1 more source
Genetic Analysis of Coxsackievirus A4 Among Healthy Children - Xizang Autonomous Region, China, 1996-2024. [PDF]
Xiao K +14 more
europepmc +1 more source
Development of a lethal adult mouse model of Coxsackievirus B1 infection for antiviral research. [PDF]
Fang C +14 more
europepmc +1 more source
The epidemiology and disease burden of enterovirus infections among hospitalized children in China: An 8-year national cross-sectional study. [PDF]
Wang Y +8 more
europepmc +1 more source
Surveillance of enterovirus infection and genotypes/subgenotypes of enteroviruses in Dak Lak, Vietnam in 2022-2024. [PDF]
Le TV +5 more
europepmc +1 more source
Comprehensive preclinical evaluation of second-generation miRNA-regulated Coxsackievirus B3-BHP: Potent antitumor efficacy and safety. [PDF]
Sakashita Y +9 more
europepmc +1 more source

